SARS-CoV-2 T-cell Peptide Antigens Set – 0.25 mg Net

Overview

The SARS-CoV-2 T-cell Peptide Antigens Set is an essential tool for researchers studying the immune response to the SARS-CoV-2 virus. This kit contains six distinct T-cell epitopes derived from the spike protein sequence of the virus, each carefully selected through in silico studies to ensure their relevance in immunological research. With each peptide provided in a net quantity of 0.25 mg, this set is ideal for various applications, including vaccine development, immune profiling, and therapeutic testing.

Key Features

• Contains six unique peptides derived from the SARS-CoV-2 spike protein sequence.
• Each peptide is provided in a separate vial with a net weight of 0.25 mg.
• Designed for studies related to T-cell responses and vaccine research.
• Facilitates the production of specific antibodies for detection and quantification.
• Compatible with a range of experimental applications in immunology.

Specifications

FAQ

What are T-cell epitopes?

T-cell epitopes are specific portions of proteins that are recognized by T-cells, which play a crucial role in the immune response by identifying and targeting infected cells.

How can these peptides be used in research?

These peptides can be utilized in a variety of research applications, including the evaluation of T-cell responses to SARS-CoV-2, vaccine development, and the creation of immunoassays to detect specific immune reactions.

Are these peptides suitable for in vitro studies?

Yes, the SARS-CoV-2 T-cell Peptide Antigens Set is designed for in vitro studies, making it an excellent choice for laboratory research focused on T-cell activity and responses.

To complement your research, consider exploring our other peptides or our specialized PKG Substrate products for advanced applications in proteomics.

Related Products

• Autocamtide-2 [KKALRRQETVDAL]
• CREBtide [KRREILSRRPSYR], 5-FAM labeled